NovaBay Pharmaceuticals rises on launch of psoriasis cream

Stablecoin Development

21/04/2023 12:55

** Shares of biopharma consumer products co NovaBay
Pharmaceuticals  NBY.N  up 11.7% at $1.72 premarket
    ** Co to launch a new cream to be used for the treatment of
psoriasis, a skin disease that causes a rash with itchy, scaly
patches
    ** Product will be available on DERMAdoctor.com and Amazon
for $46 for a single tube beginning July 31
    ** Co acquired skincare company DERMAdoctor, the
manufacturer of the new cream, in Sept 2021
    ** NBY stock down 21.03% YTD

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))